Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research: Oct 6, 2005

Premium
NIH Grants for Pharmacogenomics Research FY'05
September 12 – October 2*
City, State, or Country Name
Organization Name
Principal Investigator
Award
Title
Arizona
Tucson
University of Arizona Futscher, Bernard W
$250,038
Genomic Methylation: A Mechanism to Alter Tumor Phenotype
California
Irvine
University of California Irvine Bunney, William E
$1,882,019
Genomic Studies in Bipolar and Major Depression
Los Angeles University of California Los Angeles Licinio,
Julio
$50,000
UCLA Pharmacogenetics and Pharmacogenomics Research Group
Pasadena Epicentre Software Ryutov,
Alex
$604,534
Integrated SNP, gene expression and proteomic analysis
Santa Cruz University of California Santa Cruz Kern,
Andrew D
$42,068
Human Population Genomics
Stanford Stanford University Davis,
Ronald W
$8,000,000
Functional Genomics and Technology
Connecticut Hamden RxGen, Inc. Lawrence, Matthew S
$512,528
Toxicogenomics of Hepatotoxicity in Monkeys
Washington, DC Georgetown University Tang,
Careen K
$257,632
Coexpression of EGFRvlll/ErbB2 in Human Breast Cancer
Georgia
Atlanta
Morehouse School of Medicine Sridaran, Rajagopala
$71,000
Genomic Fingerprint of PGF2alpha and LH actions on the *
Illinois
Chicago
University of Illinois at Chicago Owley, Thomas B
$171,108
A Pharmacogenetic Study of Escitalopram in Autism
Kansas
Kansas City
University of Kansas Medical Center Li, Jonathan
$327,075
Genomic Instability and Etiology of Estrogen Oncogenesis
Maryland
Baltimore
University of Maryland Baltimore Shuldiner, Alan R
$1,335,443
Pharmacogenomics of CVD risk Reduction
Gaithersburg Meso Scale Diagnostics, LLC Schaefer, Timothy S
$232,750
Role of Stat3alpha in mutant EGFR signaling in Glioma
Massachusetts
Boston
Dana-Farber Cancer Institute Golub,
Todd R
$336,685
Functional Genomic Dissection of Refractory Anemia
Boston Harvard University Medical School Church, George M
$406,668
Molecular and Genomic Imaging Center
Cambridge Massachusetts Institute of Technology Altshuler, David M
$1,726,169
Design/Production of Haplotype Map of the Human Genome
Cambridge Massachusetts Institute of Technology Rioux,
John D
$254,538
Identifying IBD risk alleles using haplotype analysis
North Carolina
Chapel Hill
University of North Carolina Chapel Hill Rinella,
Erica S
$27,170
Effects of CAMs on EGFR-Targeted Therapy
Pennsylvania
Philadelphia
University of Pennsylvania Lerman, Caryn E
$230,618
Pharmacogenetic Investigation of Naltrexone
Pittsburgh University of Pittsburgh Sanghera, Dharambir K
$126,522
Indo-US Collaboration in Genomic Studies on Diabetes
Spain
Barcelona
Municipal Institute of Medical Research Delatorre, Rafael
$189,000
Metabolism and Pharmacogenetics in MDMA-Induced Toxicity
Texas
Houston
University of Texas MD Anderson Cancer Center Cinciripini, Paul M
$218,250
Pharmacogenetics, Emotional Reactivity & Smoking
United Kingdom
Guildford
University of Surrey Rayman, Margaret P
$54,000
Effect of Selenoprotein SNPs on Prostate Cancer Risk
Washington
Richland
Yahsgs, LLC Wassom, John S
$180,862
LiverTox: Advanced QSAR and Toxicogenomic Software for Hepatoxicity Prediction
Washington
Seattle
University of Washington Psaty,
Bruce M
$599,165
Pharmacoepidemiology and Pharmacogenetics of a Statin AE
Seattle University of Washington Fields, Stanley
$1,000,000
Interdisciplinary Training in Genomic Sciences
*SOURCE: US National Institutes of Health

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.